Source:http://linkedlifedata.com/resource/pubmed/id/16524802
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2006-3-9
|
pubmed:abstractText |
Heart failure is a leading cause of cardiovascular mortality and morbidity. It has been shown that inflammatory markers may play a role in the pathogenesis of heart failure. Therefore, inflammatory markers and anticytokine therapy in heart failure have become the attractive subjects in the literature. There are new studies regarding this issue in the literature. In this article, we reviewed inflammatory markers in heart failure and their prognostic significance based on the literature data.
|
pubmed:language |
tur
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1302-8723
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
51-4
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16524802-Biological Markers,
pubmed-meshheading:16524802-Cytokines,
pubmed-meshheading:16524802-Diagnosis, Differential,
pubmed-meshheading:16524802-Heart Failure,
pubmed-meshheading:16524802-Humans,
pubmed-meshheading:16524802-Predictive Value of Tests,
pubmed-meshheading:16524802-Prognosis,
pubmed-meshheading:16524802-Treatment Outcome,
pubmed-meshheading:16524802-Tumor Necrosis Factor-alpha
|
pubmed:year |
2006
|
pubmed:articleTitle |
[Inflammatory markers in heart failure].
|
pubmed:affiliation |
GATA Haydarpa?a E?itim Hastanesi, Kardiyoloji Servisi, Istanbul, Türkiye. drnamikozmen@yahoo.com
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|